Global Medical Institutes
Since 1989
ABOUT
About Us
Global Medical Institute, LLC (GMI) is an Investigative Research Company which conducts Phase I-IV human clinical trials for the pharmaceutical, biotechnology and medical devices industry through our network of wholly-owned and affiliated clinical research facilities. Each facility offers specialized care across a broad spectrum of therapeutic indications enrolling patients of diverse cultural and ethnic backgrounds. Our clinicians are all board certified within their area of expertise and are currently enrolling patients from their own private practice populations and the GMI clinical trial patient database.
For more than a decade, GMI has conducted Phase 1 through 4 outpatient studies on behalf of major pharmaceutical companies such as Merck, inVentiv Health, AbbVie and Pfizer. Our caring and professional staff is comprised of Physicians, Nurses, Study Coordinators, Regulatory Specialists and Lab Technicians who are dedicated to providing the highest level of quality patient care.
For more than a decade, GMI has conducted Phase 1 through 4 outpatient studies on behalf of major pharmaceutical companies such as Merck, inVentiv Health, AbbVie and Pfizer. Our caring and professional staff is comprised of Physicians, Nurses, Study Coordinators, Regulatory Specialists and Lab Technicians who are dedicated to providing the highest level of quality patient care.
Goals
Initiating studies rapidly: Through our wholly-owned, site network we offer individual or group contracting services depending on the needs of our clients. Whether you choose to work with one or all of our quality sites, we commit to an efficient and hassle-free experience.
Simplifying the Process: All of our sites offer the use of a Central Institutional Review Board of Sponsor choice. This allows for timely regulatory submissions. Se also can assign a centralized Project Manager to facilitate the IRB interaction and oversee each trial regardless of the site used to ensure quality and compliance, while maintaining consistent communication to the sponsor.
Accelerating the conduct: The GMI Investigators accelerate enrollment and study completion through involvement of their own private practice patients in the clinical research opportunity. In addition GMI has accumulated a robust computerized patient data base over the last decade of work which identifies prospective study participants by indication and age.
Improving the reliability and accuracy: All of the sites in the GMI network follow the same company-wide Standard Operating Procedures and investigator and coordinator training and quality programs. All of our study coordinators are members of ACRP and several of them are certified Clinical Research Coordinators (CCRC’s). Our centralized regulatory office monitors all IRB submissions from every trial and site as well as maintains our Standard Operating Procedures and training logs.
Simplifying the Process: All of our sites offer the use of a Central Institutional Review Board of Sponsor choice. This allows for timely regulatory submissions. Se also can assign a centralized Project Manager to facilitate the IRB interaction and oversee each trial regardless of the site used to ensure quality and compliance, while maintaining consistent communication to the sponsor.
Accelerating the conduct: The GMI Investigators accelerate enrollment and study completion through involvement of their own private practice patients in the clinical research opportunity. In addition GMI has accumulated a robust computerized patient data base over the last decade of work which identifies prospective study participants by indication and age.
Improving the reliability and accuracy: All of the sites in the GMI network follow the same company-wide Standard Operating Procedures and investigator and coordinator training and quality programs. All of our study coordinators are members of ACRP and several of them are certified Clinical Research Coordinators (CCRC’s). Our centralized regulatory office monitors all IRB submissions from every trial and site as well as maintains our Standard Operating Procedures and training logs.
5Jeffrey T. Apter, M.D.
The President and Medical Director of Global Medical Institutes, LLC (GMI). As President of GMI, Dr. Apter is responsible for overseeing the day-to-day management and financial well being of the company. As Medical Director and Principle Investigator for Princeton Medical Institute he directs clinical trials in the areas of CNS and General Medicine. With personal experience in over 350 trials in Depression, Anxiety, Bipolar Disorder and Alzheimer’s Disease, Dr. Apter fully understands the strict requirements associated with clinical research as well as the needs of his patients. In addition to his other duties, Dr. Apter is an attending physician at the Medical Center at Princeton and a research collaborator in the Department of Psychology at Princeton University.
The President and Medical Director of Global Medical Institutes, LLC (GMI). As President of GMI, Dr. Apter is responsible for overseeing the day-to-day management and financial well being of the company. As Medical Director and Principle Investigator for Princeton Medical Institute he directs clinical trials in the areas of CNS and General Medicine. With personal experience in over 350 trials in Depression, Anxiety, Bipolar Disorder and Alzheimer’s Disease, Dr. Apter fully understands the strict requirements associated with clinical research as well as the needs of his patients. In addition to his other duties, Dr. Apter is an attending physician at the Medical Center at Princeton and a research collaborator in the Department of Psychology at Princeton University.
Eugene Selivra, M.D
The Chief Operating Officer (COO) of Global Medical Institutes. As COO of GMI, Dr. Selivra is responsible for the day-to-day operations of all network sites, corporate financial oversight, incorporating standard operating practices, communicating and negotiating with our sponsors. Dr. Selivra has over 18 years of clinical research experience having managed and operated sites in Arkansas, Florida and New York. Most recently, Dr. Selivra established and directed Winthrop-South Nassau University Health System Clinical Trials Network on Long Island.
The Chief Operating Officer (COO) of Global Medical Institutes. As COO of GMI, Dr. Selivra is responsible for the day-to-day operations of all network sites, corporate financial oversight, incorporating standard operating practices, communicating and negotiating with our sponsors. Dr. Selivra has over 18 years of clinical research experience having managed and operated sites in Arkansas, Florida and New York. Most recently, Dr. Selivra established and directed Winthrop-South Nassau University Health System Clinical Trials Network on Long Island.